Medical Congress News

Medical Digest & Congress Report

Health EN ↓ Odcinki: 808

The MedicalDigest.org / CongressReport.eu podcast covers the latest evidence based medical news from cardiology, hematology, oncology, diabetology, pulmonology, dermatology, urology and more. Made for healthcare professionals and researchers, we are an independent, open-access platform. CongressReport.eu portal enables HCPs to get acquainted with new clinical trial results, medical diagnostic and treatment guidelines. Our non-promotional website collects and stores the relevant scientific information, KOL insights, key lectures, poster presentations in a user-friendly format.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: medicaldigest.org

Autor

Medical Congress News

Kategoria

Health

Strona podcastu

medicaldigest.org

Ostatni odcinek

20 lis 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android 10 mln+ pobrań · ocena 4,7+ iOS wkrótce

Odcinki

Early-life Exposures and Their Impact on Atopy - report from ACAAI 2026 20.11.2026

Dr. Kirsi Jarvinen-Seppo discusses early-life exposures and their impact on atopy, highlighting how the infant gut microbiome, human milk, and traditional farming versus urban environments shape early immune development and influence the risk of the atopic march, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:early-life-exposur...

Eosinophilic esophagitis for the allergist-immunologist: diagnosis, coordinated care, and epithelial cytokines - report from ACAAI 2026 20.11.2026

Dr. Brian Schroer discusses eosinophilic esophagitis (EoE) within the atopic spectrum, highlighting key strategies for early case detection, multidisciplinary coordinated care, and the therapeutic role of targeting epithelial cytokines, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:eosinophilic-esophagitis-allergist-immunologi...

Precision allergy in practice: from mechanisms to prevention - report from ACAAI 2026 20.11.2026

Dr. Mohamed Shamji discusses translating immunological mechanisms into clinical practice to advance precision allergy care and disease prevention, presented in the joint EAACI session at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:precision-allergy-practice-mechanisms-prevention

Current and emerging treatment options for food allergy - report from ACAAI 2026 20.11.2026

Dr. Thomas Chacko discusses current clinical strategies and emerging therapeutic options for managing food allergies, including allergen immunotherapy and targeted biologics, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:current-and-emerging-treatment-options-food-allergy

Navigating pediatric asthma in the precision medicine era - report from ACAAI 2026 20.11.2026

Dr. Suzanne Y. Ngo discusses individualized diagnostic strategies and targeted biologic therapies for managing pediatric asthma in the precision medicine era, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:navigating-pediatric-asthma-precision-medicine-era

Microbiome-targeted interventions: current and emerging approaches - report from ACAAI 2026 20.11.2026

Dr. Stuart Turvey discusses current clinical applications and emerging strategies for microbiome-targeted interventions in allergic diseases, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:microbiome-targeted-interventions-current-and-emerging-approaches

Epinephrine utilization and management in schools: insights from a national survey of school nurses - report from ACAAI 2026 20.11.2026

Dr. Mahi K. Singh discusses findings from a national survey of school nurses examining current practices, barriers, and opportunities for improvement in epinephrine utilization and anaphylaxis management in school settings, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:epinephrine-utilization-and-management-schools-insights-na...

Diagnosing FPIES in children and adults and identifying emerging triggers - report from ACAAI 2026 20.11.2026

Dr. Anna Nowak-Wegrzyn discusses current approaches to diagnosing food protein-induced enterocolitis syndrome (FPIES) in both pediatric and adult populations, along with newly recognized food triggers, presented at the ACAAI 2026 Annual Scientific Meeting. For more information, visit https://fpies.org Video: https://medicaldigest.org/scientific-contents/interview:diagnosing-fpies-children-and-adul...

Advancing understanding and therapy options for inducible and spontaneous urticaria - report from ACAAI 2026 20.11.2026

Dr. Sandra M. Gawchik discusses evolving clinical insights and expanding therapeutic options for managing both inducible and spontaneous urticaria, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:advancing-understanding-and-therapy-options-inducible-and-spontaneous-urticaria

Efficacy and safety of freneslerbart-mevonlerbart (REGN-2Cat) in cat allergen-induced allergic conjunctivitis - report from ACAAI 2026 20.11.2026

Dr. Deepti Deshpande discusses clinical findings evaluating the efficacy and safety of freneslerbart-mevonlerbart (REGN-2Cat) on ocular symptoms in patients with cat allergen-induced allergic conjunctivitis, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-freneslerbart-mevonlerbart-regn-2cat-cat-allergen-indu...

Sustained efficacy and safety of remibrutinib through week 52 in chronic inducible urticaria - report from ACAAI 2026 20.11.2026

Dr. Giselle S. Mosnaim discusses new clinical data demonstrating the sustained efficacy and favorable safety profile of remibrutinib over 52 weeks in patients with chronic inducible urticaria, presented at the ACAAI 2026 Annual Scientific Meeting. Video: https://medicaldigest.org/scientific-contents/interview:sustained-efficacy-and-safety-remibrutinib-through-week-52-chronic-inducible-urticaria

Revealing immunotherapy response through a patient’s living tumor - report from SITC 2026 19.11.2026

Dr. Hinco Gierman discusses what a patient’s living tumor can reveal about its response to immunotherapy, highlighting functional profiling and ex vivo testing approaches to predict treatment efficacy at the SITC 2026 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:revealing-immunotherapy-response-through-patients-living-tumor

Overcoming barriers in immuno-oncology at immune-privileged sites - report from SITC 2026 19.11.2026

Professor Hideho Okada discusses the unique challenges and emerging strategies for advancing immuno-oncology therapies within immune-privileged sites, such as the central nervous system, presented at the SITC 2026 Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:overcoming-barriers-immuno-oncology-immune-privileged-sites

Recent advances in the treatment of platinum-resistant ovarian cancer - report from ESMO 2026 10.11.2026

Professor Domenica Lorusso explores the latest therapeutic advances and emerging strategies for managing platinum-resistant ovarian cancer after the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:recent-advances-treatment-platinum-resistant-ovarian-cancer

KEYNOTE-C93: First-line pembrolizumab vs chemotherapy in dMMR advanced or recurrent endometrial carcinoma - report from ESMO 2026 04.11.2026

Doctor Brian M. Slomovitz presents Phase 3 KEYNOTE-C93/GOG-3064/ENGOT-en15 data evaluating first-line pembrolizumab monotherapy versus carboplatin plus paclitaxel in mismatch repair-deficient (dMMR) advanced or recurrent endometrial carcinoma at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:keynote-c93-first-line-pembrolizumab-vs-chemotherapy-dmmr-advanced-...

KEYNOTE-B49: Pembrolizumab plus chemotherapy in HR+/HER2− advanced breast cancer - report from ESMO 2026 04.11.2026

Doctor Hope S. Rugo presents results from the Phase 3 KEYNOTE-B49 study evaluating pembrolizumab versus placebo in combination with chemotherapy in patients with HR+/HER2− advanced breast cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:keynote-b49-pembrolizumab-plus-chemotherapy-hrher2-advanced-breast-cancer

Advances in brain metastases management in breast cancer - report from ESMO 2026 04.11.2026

Professor Hope S. Rugo discusses key advances, targeted systemic options, and novel treatment strategies in managing brain metastases in patients with metastatic breast cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:advances-brain-metastases-management-breast-cancer

DeLLphi-305: Tarlatamab plus durvalumab as 1L maintenance in extensive-stage SCLC - report from ESMO 2026 04.11.2026

Doctor Jacob Sands presents primary analysis data from the Phase 3 DeLLphi-305 trial, evaluating tarlatamab plus durvalumab versus durvalumab alone as first-line maintenance therapy for patients with extensive-stage small cell lung cancer (ES-SCLC) at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:available-research-guiding-selection-therapy-patients-chronic...

Melanoma and skin tumours highlights from ESMO 2026 04.11.2026

Professor Karijn Suijkerbuijk summarizes the most important practice-changing trials, therapeutic updates, and clinical highlights in melanoma and other skin tumours presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:melanoma-and-skin-tumours-highlights-esmo-2026

Novelties in the treatment of colon cancer at ESMO 2026 04.11.2026

Professor Julien Taieb highlights key therapeutic novelties, emerging clinical trial results, and evolving treatment paradigms in colon cancer presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:novelties-treatment-colon-cancer-esmo-2026

A patient perspective on living with KRAS-mutated lung cancer - report from ESMO 2026 04.11.2026

Terri D. Conneran shares a powerful patient perspective on living with KRAS-mutated lung cancer and advancing the frontiers of patient-centric care at the ESMO Congress 2026. For more information and resources, visit the KRAS Kickers website. Video: https://medicaldigest.org/scientific-contents/interview:patient-perspective-living-kras-mutated-lung-cancer

INTerpath-001: Adjuvant mRNA neoantigen therapy intismeran plus pembrolizumab in resected stage IIB–IV melanoma - report from ESMO 2026 04.11.2026

Professor Georgina V. Long presents the Phase III INTerpath-001 trial results evaluating the mRNA-based individualized neoantigen therapy intismeran autogene in combination with pembrolizumab versus pembrolizumab alone as adjuvant treatment for patients with resected stage IIB–IV melanoma at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:interpath-001-adjuva...

Head and neck cancer highlights from ESMO 2026 03.11.2026

Professor Amanda Psyrri summarizes the most important practice-changing trial results, emerging biomarker data, and therapeutic advances in head and neck cancer presented at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:head-and-neck-cancer-highlights-esmo-2026

Key clinical updates in gastroesophageal cancer: HERIZON-GEA-01 and CLARITY-Gastric 01 - report from ESMO 2026 03.11.2026

Professor Kohei Shitara discusses key findings from two pivotal late-breaking trials in gastroesophageal cancer presented at the ESMO Congress 2026: the HERIZON-GEA-01 study and the CLARITY-Gastric 01 trial. Video: https://medicaldigest.org/scientific-contents/interview:key-clinical-updates-gastroesophageal-cancer-herizon-gea-01-and-clarity-gastric-01

Advancing clinical practice and patient care in gastroesophageal cancer - report from ESMO 2026 03.11.2026

Doctor Kohei Shitara highlights key advances in clinical practice, evolving therapeutic strategies, and patient care management in gastroesophageal cancer at the ESMO Congress 2026. Video: https://medicaldigest.org/scientific-contents/interview:advancing-clinical-practice-and-patient-care-gastroesophageal-cancer

Słuchaj podcastu Medical Digest & Congress Report w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS